Building A Quality & Safety Infrastructure: The Harris Center Case Study is starting in

34% Of Community-Outpatient Behavioral Health Facilities Offer Medications To Treat Opioid Use Disorder

In a 20-state review, about 34% of community outpatient mental health facilities offered medications to treat opioid use disorder (MOUD), such as buprenorphine, naltrexone, or methadone. Among the 450 facilities and clinics included in the review, 51% of Certified Community Behavioral Health Clinics (CCBHCs) and 33% of non-CCBHCs offered MOUD.

Facilities with the following characteristics were more likely to offer MOUD:

Structured as a CCBHC: Odds of MOUD were 2.11 times higher than non-CCBHCs.

Provide integrated mental and addiction treatment: Odds of MOUD were 5.21 times higher than non-integrated facilities.

Offer a specialized program . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.